143 related articles for article (PubMed ID: 9575571)
21. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
Kitchens RL; Thompson PA
J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
[TBL] [Abstract][Full Text] [Related]
22. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I
Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918
[TBL] [Abstract][Full Text] [Related]
23. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
[TBL] [Abstract][Full Text] [Related]
24. CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS.
Kitchens RL; Munford RS
J Immunol; 1998 Feb; 160(4):1920-8. PubMed ID: 9469454
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
Ren L; Leung WK; Loo TW; Jin L
J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094
[TBL] [Abstract][Full Text] [Related]
26. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
27. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
Ohnishi T; Muroi M; Tanamoto K
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
[TBL] [Abstract][Full Text] [Related]
28. CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria.
Heumann D
J Endotoxin Res; 2001; 7(6):439-41. PubMed ID: 11753213
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Troelstra A; de Graaf-Miltenburg LA; van Bommel T; Verhoef J; Van Kessel KP; Van Strijp JA
J Immunol; 1999 Apr; 162(7):4220-5. PubMed ID: 10201950
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide recognition protein, MD-2, facilitates cellular uptake of E. coli-derived plasmid DNA in synovium.
Kolka JA; Vreede AP; Roessler BJ
J Gene Med; 2005 Jul; 7(7):956-64. PubMed ID: 15772934
[TBL] [Abstract][Full Text] [Related]
31. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2.
Koraha J; Tsuneyoshi N; Kimoto M; Gauchat JF; Nakatake H; Fukudome K
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1292-7. PubMed ID: 16275943
[TBL] [Abstract][Full Text] [Related]
32. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
Means TK; Lien E; Yoshimura A; Wang S; Golenbock DT; Fenton MJ
J Immunol; 1999 Dec; 163(12):6748-55. PubMed ID: 10586073
[TBL] [Abstract][Full Text] [Related]
33. Roles for LBP and soluble CD14 in cellular uptake of LPS.
Tapping RI; Gegner JA; Kravchenko VV; Tobias PS
Prog Clin Biol Res; 1998; 397():73-8. PubMed ID: 9575548
[TBL] [Abstract][Full Text] [Related]
34. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
Lee JW; Paape MJ; Zhao X
Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
[TBL] [Abstract][Full Text] [Related]
35. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay.
Yu W; Soprana E; Cosentino G; Volta M; Lichenstein HS; Viale G; Vercelli D
J Immunol; 1998 Oct; 161(8):4244-51. PubMed ID: 9780199
[TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
37. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding.
Juan TS; Hailman E; Kelley MJ; Wright SD; Lichenstein HS
J Biol Chem; 1995 Jul; 270(29):17237-42. PubMed ID: 7542233
[TBL] [Abstract][Full Text] [Related]
38. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
Grunwald U; Krüger C; Schütt C
Circ Shock; 1993 Mar; 39(3):220-5. PubMed ID: 7680967
[TBL] [Abstract][Full Text] [Related]
39. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli.
Stelter F; Bernheiden M; Menzel R; Jack RS; Witt S; Fan X; Pfister M; Schütt C
Eur J Biochem; 1997 Jan; 243(1-2):100-9. PubMed ID: 9030727
[TBL] [Abstract][Full Text] [Related]
40. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
Haziot A; Rong GW; Silver J; Goyert SM
J Immunol; 1993 Aug; 151(3):1500-7. PubMed ID: 7687634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
